Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young International Inc. (NASDAQ: SY), China's leading aesthetic treatment platform, has scheduled its first quarter 2025 financial results announcement for May 16, 2025, before U.S. markets open. The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 23, 2025, and interested parties can also access a live and archived webcast of the conference call through the company's investor relations website.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024. The report was submitted to the Securities and Exchange Commission on April 18, 2025.
The annual report is accessible through the company's investor relations website at ir.soyoung.com. Shareholders and ADS holders can request a complimentary hard copy of the annual report, which includes audited consolidated financial statements, by emailing ir@soyoung.com.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, announced that its CEO and chairman Mr. Xing Jin, through Beauty & Health Holdings , has purchased 4,544,820 American depositary shares (ADSs) representing 3,496,015.38 Class A ordinary shares in the open market on March 31, 2025.
The purchase was made at US$0.90 per ADS, totaling US$4,090,338, using personal funds. This transaction increased Jin's beneficial ownership to 24.9% of the company's outstanding shares. The purchase was executed in accordance with Rule 10b-18 of the Securities Exchange Act of 1934.
The company's directors stated that the share purchase is not expected to materially impact So-Young's financial position or business operations. Jin expressed that this purchase reflects his continued confidence in the company's long-term growth prospects.
So-Young International (SY) reported its Q4 and FY2024 financial results, showing mixed performance. Q4 total revenues decreased 5.5% to RMB369.2 million (US$50.6 million) compared to 2023. The company recorded a significant net loss of RMB607.6 million (US$83.2 million), primarily due to a one-time goodwill impairment charge of RMB540.0 million for Wuhan Miracle subsidiary.
Notable operational highlights include the expansion to 19 aesthetic centers across nine major cities, with 11 centers achieving positive monthly operating cash flow. Aesthetic treatment services revenue grew substantially by 701.6% to RMB81.3 million. The company maintains a 60% customer retention rate and served over 1,200 institutions with supply chain solutions.
The board declared a special cash dividend of US$0.03445 per ordinary share (US$0.0265 per ADS), with approximately US$3 million total distribution planned for April 25, 2025.
So-Young International (NASDAQ: SY), China's largest medical aesthetics social community, has announced a rescheduling of its Q4 and full year 2024 financial results release. The results will now be presented before U.S. markets open on March 28, 2025, followed by a management earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time) on the same day.
So-Young International (NASDAQ: SY), China's leading social community platform in the medical aesthetics industry, has announced it will release its Q4 and full year 2024 financial results on March 20, 2025, before U.S. markets open.
The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 27, 2025, and interested parties can also access the webcast through the company's investor relations website.
So-Young International (NASDAQ: SY) announced its transfer from Nasdaq Global Market to Nasdaq Capital Market, effective February 27, 2025. This transition follows the company's non-compliance with Nasdaq's minimum bid price requirement, as its ADS price remained below $1.00 for 30 consecutive business days since August 29, 2024.
The transfer will not impact ADS trading, which continues under the symbol 'SY'. With this move, Nasdaq has granted So-Young an additional 180-day period until August 25, 2025, to regain compliance by maintaining a closing bid price above $1.00 for at least 10 consecutive business days. The company, China's largest medical aesthetics social community, is actively monitoring its ADS price and exploring options to address this deficiency.
So-Young International reported Q3 2024 financial results with total revenues of RMB371.8 million (US$53.0 million), down 3.5% year-over-year but exceeding guidance. Net income rose to RMB20.3 million (US$2.9 million), up from RMB18.3 million in Q3 2023. Sales of medical products grew 18.7% year-over-year, while information services revenue declined 8.0%. The company expanded its clinic network to 16 stores and improved operational efficiency, resulting in an 8.1% decrease in operating expenses. For Q4 2024, So-Young expects revenues between RMB350.0-370.0 million, representing a 5.3-10.4% year-over-year decrease.
So-Young International Inc. (NASDAQ: SY), China's largest medical aesthetics social community, has announced it will release its third quarter 2024 financial results on November 20, 2024, before U.S. markets open. The company will host an earnings conference call at 7:00 AM U.S. Eastern Time on the same day. A telephone replay will be available until November 27, 2024, and a webcast will be accessible through the company's investor relations website.
So-Young International Inc. (Nasdaq: SY), China's largest medical aesthetics social community, has received a notification from Nasdaq due to its American depositary shares (ADSs) closing bid price falling below $1.00 for 30 consecutive business days. This violates Nasdaq Listing Rule 5450(a)(1). The company has been given a 180-day compliance period until February 24, 2025, to regain compliance by maintaining a closing bid price of $1.00 or higher for at least ten consecutive business days. If unsuccessful, So-Young may be eligible for an additional 180-day period, subject to meeting other listing requirements. The company assures that this notice does not affect its current listing, trading, or business operations, and it will take all reasonable measures to regain compliance within the grace period.